Home   Search   Browse   Statistics   User guide   FAQs   Post question   Download   Process data  
Search results for the GEO ID: GSE13276
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM335185
GPL96
Core sample 1 Human glioblastoma tumor mass Tumor mass samples were retrieved from patients operated for supratentorial GBM with "en bloc" total removal technique. All specimens were collected and submitted to the study under institutional review board-approved protocols. Classification and grading of the tumors were performed according to the criteria of the World Health Organization (WHO). All tumors included in this protocol were classified as WHO grade IV. Glioblastoma is a highly locally invasive tumor. Key genetic mutations defining GBM are well-characterized, while poor informations are available about the surrounding tumor tissue, that represents the site of tumor recurrence in 90% of the cases. Knowledges of the molecular mechanisms that encode this invasive phenotype may help to develop new therapeutic options.
GSM335186
GPL96
Core sample 2 Human glioblastoma tumor mass Tumor mass samples were retrieved from patients operated for supratentorial GBM with "en bloc" total removal technique. All specimens were collected and submitted to the study under institutional review board-approved protocols. Classification and grading of the tumors were performed according to the criteria of the World Health Organization (WHO). All tumors included in this protocol were classified as WHO grade IV. Glioblastoma is a highly locally invasive tumor. Key genetic mutations defining GBM are well-characterized, while poor informations are available about the surrounding tumor tissue, that represents the site of tumor recurrence in 90% of the cases. Knowledges of the molecular mechanisms that encode this invasive phenotype may help to develop new therapeutic options.
GSM335187
GPL96
Core sample 3 Human glioblastoma tumor mass Tumor mass samples were retrieved from patients operated for supratentorial GBM with "en bloc" total removal technique. All specimens were collected and submitted to the study under institutional review board-approved protocols. Classification and grading of the tumors were performed according to the criteria of the World Health Organization (WHO). All tumors included in this protocol were classified as WHO grade IV. Glioblastoma is a highly locally invasive tumor. Key genetic mutations defining GBM are well-characterized, while poor informations are available about the surrounding tumor tissue, that represents the site of tumor recurrence in 90% of the cases. Knowledges of the molecular mechanisms that encode this invasive phenotype may help to develop new therapeutic options.
GSM335188
GPL96
Core sample 4 Human glioblastoma tumor mass Tumor mass samples were retrieved from patients operated for supratentorial GBM with "en bloc" total removal technique. All specimens were collected and submitted to the study under institutional review board-approved protocols. Classification and grading of the tumors were performed according to the criteria of the World Health Organization (WHO). All tumors included in this protocol were classified as WHO grade IV. Glioblastoma is a highly locally invasive tumor. Key genetic mutations defining GBM are well-characterized, while poor informations are available about the surrounding tumor tissue, that represents the site of tumor recurrence in 90% of the cases. Knowledges of the molecular mechanisms that encode this invasive phenotype may help to develop new therapeutic options.
GSM335189
GPL96
Core sample 5 Human glioblastoma tumor mass Tumor mass samples were retrieved from patients operated for supratentorial GBM with "en bloc" total removal technique. All specimens were collected and submitted to the study under institutional review board-approved protocols. Classification and grading of the tumors were performed according to the criteria of the World Health Organization (WHO). All tumors included in this protocol were classified as WHO grade IV. Glioblastoma is a highly locally invasive tumor. Key genetic mutations defining GBM are well-characterized, while poor informations are available about the surrounding tumor tissue, that represents the site of tumor recurrence in 90% of the cases. Knowledges of the molecular mechanisms that encode this invasive phenotype may help to develop new therapeutic options.
GSM335190
GPL96
GBM surrounding tissue 1 GBM surrounding tissue GBM surrounding tissue was retrieved from not infiltrated white matter sited at 2cm from the macroscopic tumor border. Glioblastoma is a highly locally invasive tumor. Key genetic mutations defining GBM are well-characterized, while poor informations are available about the surrounding tumor tissue, that represents the site of tumor recurrence in 90% of the cases. Knowledges of the molecular mechanisms that encode this invasive phenotype may help to develop new therapeutic options.
GSM335191
GPL96
GBM surrounding tissue 2 GBM surrounding tissue GBM surrounding tissue was retrieved from not infiltrated white matter sited at 2cm from the macroscopic tumor border. Glioblastoma is a highly locally invasive tumor. Key genetic mutations defining GBM are well-characterized, while poor informations are available about the surrounding tumor tissue, that represents the site of tumor recurrence in 90% of the cases. Knowledges of the molecular mechanisms that encode this invasive phenotype may help to develop new therapeutic options.
GSM335192
GPL96
GBM surrounding tissue 3 GBM surrounding tissue GBM surrounding tissue was retrieved from not infiltrated white matter sited at 2cm from the macroscopic tumor border. Glioblastoma is a highly locally invasive tumor. Key genetic mutations defining GBM are well-characterized, while poor informations are available about the surrounding tumor tissue, that represents the site of tumor recurrence in 90% of the cases. Knowledges of the molecular mechanisms that encode this invasive phenotype may help to develop new therapeutic options.
GSM335193
GPL96
GBM surrounding tissue 3R GBM surrounding tissue GBM surrounding tissue was retrieved from not infiltrated white matter sited at 2cm from the macroscopic tumor border. This is a biological replicate of GBM surrounding tissue 3, harvested independently. Glioblastoma is a highly locally invasive tumor. Key genetic mutations defining GBM are well-characterized, while poor informations are available about the surrounding tumor tissue, that represents the site of tumor recurrence in 90% of the cases. Knowledges of the molecular mechanisms that encode this invasive phenotype may help to develop new therapeutic options.
GSM335194
GPL96
GBM surrounding tissue 4 GBM surrounding tissue GBM surrounding tissue was retrieved from not infiltrated white matter sited at 2cm from the macroscopic tumor border. Glioblastoma is a highly locally invasive tumor. Key genetic mutations defining GBM are well-characterized, while poor informations are available about the surrounding tumor tissue, that represents the site of tumor recurrence in 90% of the cases. Knowledges of the molecular mechanisms that encode this invasive phenotype may help to develop new therapeutic options.
GSM335195
GPL96
GBM surrounding tissue 4R GBM surrounding tissue GBM surrounding tissue was retrieved from not infiltrated white matter sited at 2cm from the macroscopic tumor border. This sample is a biological replicate of GBM surrounding tissue sample 4, harvested independently. Glioblastoma is a highly locally invasive tumor. Key genetic mutations defining GBM are well-characterized, while poor informations are available about the surrounding tumor tissue, that represents the site of tumor recurrence in 90% of the cases. Knowledges of the molecular mechanisms that encode this invasive phenotype may help to develop new therapeutic options.
GSM335196
GPL96
GBM surrounding tissue 5 GBM surrounding tissue GBM surrounding tissue was retrieved from not infiltrated white matter sited at 2cm from the macroscopic tumor border. Glioblastoma is a highly locally invasive tumor. Key genetic mutations defining GBM are well-characterized, while poor informations are available about the surrounding tumor tissue, that represents the site of tumor recurrence in 90% of the cases. Knowledges of the molecular mechanisms that encode this invasive phenotype may help to develop new therapeutic options.
GSM335197
GPL96
White matter control 1 human white matter White matter control biopsies were retrieved from patients operated on for deep intracerebral cavernomas. Glioblastoma is a highly locally invasive tumor. Key genetic mutations defining GBM are well-characterized, while poor informations are available about the surrounding tumor tissue, that represents the site of tumor recurrence in 90% of the cases. Knowledges of the molecular mechanisms that encode this invasive phenotype may help to develop new therapeutic options.
GSM335198
GPL96
White matter control 2 human white matter White matter control biopsies were retrieved from patients operated on for deep intracerebral cavernomas. Glioblastoma is a highly locally invasive tumor. Key genetic mutations defining GBM are well-characterized, while poor informations are available about the surrounding tumor tissue, that represents the site of tumor recurrence in 90% of the cases. Knowledges of the molecular mechanisms that encode this invasive phenotype may help to develop new therapeutic options.
GSM335199
GPL96
White matter control 3 human white matter White matter control biopsies were retrieved from patients operated on for deep intracerebral cavernomas. Glioblastoma is a highly locally invasive tumor. Key genetic mutations defining GBM are well-characterized, while poor informations are available about the surrounding tumor tissue, that represents the site of tumor recurrence in 90% of the cases. Knowledges of the molecular mechanisms that encode this invasive phenotype may help to develop new therapeutic options.
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes